The 9th Asian & Oceanic epilepsy Congress
The 9th Asian & Oceanic epilepsy Congress was recently concluded in Manilla, Phillipines. In this conference UCB had brought together 4 key experts from...
Higher-Volume Rehab Centers Better for Hip Fracture Recovery: Study
Seniors who break a hip receive the best care in skilled nursing facilities with the most experience handling such fractures, a new study suggests....
GSK obtains Japanese approval for Encruse Ellipta to treat COPD
GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for...
CDSCO Ahmedabad becomes first ISO certified zonal regulatory office in India
In a strategic development, the zonal office of Central Drugs Standard Control Organisation (CDSCO) Ahmedabad was recognised with the certification of ISO 9001:2008 standards...
Bangalore – The Silicon City, is now the Pharma City
"There is no second thought on the capability of the Indian pharma industry and Bangalore is gearing up to play its role as a...
Gilead partners with 7 Indian pharma cos to expand its access to hep C drugs in developing countries
Gilead Sciences entered into an non-exclusive licencing agreements with seven India-based generic pharma manufacturers to expand access to its chronic hepatitis C medicines in...
India’s drug industry to touch $48 billion by 2018
India’s drugs and pharmaceuticals industry is likely to post total sales of Rs.2.91 trillion ($47.88 billion) by 2018, with an average yearly growth of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...